ArticleOncotarget2017

Serum miR-143 levels predict the pathological response to neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.

Yukiharu Hiyoshi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.